<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04354688</url>
  </required_header>
  <id_info>
    <org_study_id>1802</org_study_id>
    <nct_id>NCT04354688</nct_id>
  </id_info>
  <brief_title>T3 Certain Tapered With DCD vs T3 Certain Tapered Non-DCD</brief_title>
  <acronym>Apple</acronym>
  <official_title>A Prospective, Randomized, Comparative Clinical Study of the Safety, Efficacy and Clinical Benefits of the T3 Certain Tapered With DCD Implant System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a prospective, randomized multicenter study to determine the safety and efficacy&#xD;
      of the T3 Certain Tapered with DCD as compared to T3 Certain Tapered without DCD. All&#xD;
      implants will be placed in the maxilla or mandible in a single stage manner and loaded with&#xD;
      prosthesis after 6 weeks of healing. Final restorations will take place no later than 4&#xD;
      months following implant placement surgery. The implants will be evaluated yearly for 2&#xD;
      years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, prospective, randomized study that will assess the the safety and&#xD;
      efficacy of the implant systems with:&#xD;
&#xD;
        -  Resistance to countertorque testing (mobility)&#xD;
&#xD;
        -  Implant Stability Quotient (ISQ)&#xD;
&#xD;
        -  Changes in peri-implant crestal bone levels&#xD;
&#xD;
        -  Confirmation of clinical benefits&#xD;
&#xD;
      A total of 60 implants, 30 per treatment group will be placed across all participating sites.&#xD;
      One patient may contribute more than 1 implant. All implants/ patients will be followed for&#xD;
      up to 2 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 19, 2019</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Test implant- T3 Certain Tapered implant with DCD Active Comparator- T3 Certain Tapered implant without DCD</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>2 years</time_frame>
    <description>Assessed by lack of mobility, resistance to countertorque testing, implant stability measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-implant crestal bone levels</measure>
    <time_frame>2 years</time_frame>
    <description>Assessed by radiographic measurements of serial crestal bone levels</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Edentulous Jaw</condition>
  <arm_group>
    <arm_group_label>T3 Certain Tapered implant with DCD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implant will be placed in the maxilla or mandible in a single stage manner and loaded with prosthesis after 6 weeks of healing. Final restorations will take place no later than 4 months following implant placement surgery. The implants will be evaluated yearly for 2 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T3 Certain Tapered implant without DCD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implant will be placed in the maxilla or mandible in a single stage manner and loaded with prosthesis after 6 weeks of healing. Final restorations will take place no later than 4 months following implant placement surgery. The implants will be evaluated yearly for 2 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>T3 Certain Tapered Implant</intervention_name>
    <description>Patients will be randomized to receive either the T3 Certain Tapered with DCD (Test) or the T3 Certain Tapered without DCD (control/active comparator). Both types of implants will be rehabilitated in the same manner (early loading)</description>
    <arm_group_label>T3 Certain Tapered implant with DCD</arm_group_label>
    <arm_group_label>T3 Certain Tapered implant without DCD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients of either sex and greater than 18 years of age&#xD;
&#xD;
          2. Patients for whom a decision has already been made to use a dental implant in the&#xD;
             mandible or maxilla.&#xD;
&#xD;
          3. Immediate extraction or a prior extracted site&#xD;
&#xD;
          4. Patients must be physically able to tolerate conventional surgical and restorative&#xD;
             procedures.&#xD;
&#xD;
          5. Presence of opposing dentition&#xD;
&#xD;
          6. Patients who provide a signed informed consent.&#xD;
&#xD;
          7. Patients who agree to be evaluated for each study visit.&#xD;
&#xD;
          8. Minimum primary stability, insertion torque &gt; 35Ncm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with known systemic diseases such as uncontrolled diabetes, endocrine&#xD;
             disease, heart disease, immuno-compromised, or mental disorders.&#xD;
&#xD;
          2. Patients with current use of non-steroidal anti-inflammatory drugs, bisphosphonates or&#xD;
             corticosteroid treatments.&#xD;
&#xD;
          3. Patients with active infection or severe inflammation in the areas intended for&#xD;
             implant placement.&#xD;
&#xD;
          4. Patients with a &gt; 10 cigarette per day smoking habit.&#xD;
&#xD;
          5. Patients with a history of therapeutic radiation to the head or jaw.&#xD;
&#xD;
          6. Patients who are known to be pregnant at the screening visit or planning to become&#xD;
             pregnant within 6 months of study enrollment.&#xD;
&#xD;
          7. Patients with evidence of severe parafunctional habits such as bruxing or clenching.&#xD;
&#xD;
          8. Patients with HIV or Hepatitis infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital San Jose</name>
      <address>
        <city>Providencia</city>
        <state>Santiago</state>
        <zip>1102</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. George Papavasiliou</name>
      <address>
        <city>Athens</city>
        <zip>15231</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
    <country>Greece</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2020</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaw, Edentulous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

